216 related articles for article (PubMed ID: 27160664)
21. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.
Han M; Vakili MR; Soleymani Abyaneh H; Molavi O; Lai R; Lavasanifar A
Mol Pharm; 2014 Aug; 11(8):2640-9. PubMed ID: 24811541
[TBL] [Abstract][Full Text] [Related]
22. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
Yang X; Cai X; Yu A; Xi Y; Zhai G
J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
[TBL] [Abstract][Full Text] [Related]
23. Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling.
Weber T; Dalen H; Andera L; Nègre-Salvayre A; Augé N; Sticha M; Lloret A; Terman A; Witting PK; Higuchi M; Plasilova M; Zivny J; Gellert N; Weber C; Neuzil J
Biochemistry; 2003 Apr; 42(14):4277-91. PubMed ID: 12680782
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide.
Palao-Suay R; Aguilar MR; Parra-Ruiz FJ; Martín-Saldaña S; Rohner NA; Thomas SN; San Román J
J Mater Sci Mater Med; 2017 Aug; 28(10):152. PubMed ID: 28861765
[TBL] [Abstract][Full Text] [Related]
25. Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers.
Liang DS; Su HT; Liu YJ; Wang AT; Qi XR
Biomaterials; 2015 Dec; 71():11-23. PubMed ID: 26310359
[TBL] [Abstract][Full Text] [Related]
26. Enhanced cytotoxicity to lung cancer cells by mitochondrial delivery of camptothecin.
Xie J; Wang H; Huang Q; Lin J; Wen H; Miao Y; Lv L; Ruan D; Yu X; Qin L; Zhou Y
Eur J Pharm Sci; 2023 Oct; 189():106561. PubMed ID: 37562549
[TBL] [Abstract][Full Text] [Related]
27. Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells.
Mallick A; More P; Ghosh S; Chippalkatti R; Chopade BA; Lahiri M; Basu S
ACS Appl Mater Interfaces; 2015 Apr; 7(14):7584-98. PubMed ID: 25811662
[TBL] [Abstract][Full Text] [Related]
28. Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer.
Wang Z; Qin Y; Wang X; Zhang T; Hu Y; Wang D; Zhang L; Zhu Y
Int J Nanomedicine; 2023; 18():4023-4042. PubMed ID: 37520302
[TBL] [Abstract][Full Text] [Related]
29. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q
ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220
[TBL] [Abstract][Full Text] [Related]
30. Dog-bone shaped gold nanoparticle-mediated chemo-photothermal therapy impairs the powerhouse to trigger apoptosis in cancer cells.
Ingle J; Uttam B; Panigrahi R; Khatua S; Basu S
J Mater Chem B; 2023 Oct; 11(40):9732-9741. PubMed ID: 37791575
[TBL] [Abstract][Full Text] [Related]
31. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
32. Chimeric Nanoparticle: A Platform for Simultaneous Targeting of Phosphatidylinositol-3-Kinase Signaling and Damaging DNA in Cancer Cells.
Palvai S; More P; Mapara N; Basu S
ACS Appl Mater Interfaces; 2015 Aug; 7(33):18327-35. PubMed ID: 26258746
[TBL] [Abstract][Full Text] [Related]
33. Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?
Swettenham E; Witting PK; Salvatore BA; Neuzil J
J Neurochem; 2005 Sep; 94(5):1448-56. PubMed ID: 16001965
[TBL] [Abstract][Full Text] [Related]
34. Complex Mitochondrial Dysfunction Induced by TPP
Fuentes-Retamal S; Sandoval-Acuña C; Peredo-Silva L; Guzmán-Rivera D; Pavani M; Torrealba N; Truksa J; Castro-Castillo V; Catalán M; Kemmerling U; Urra FA; Ferreira J
Cells; 2020 Feb; 9(2):. PubMed ID: 32053908
[TBL] [Abstract][Full Text] [Related]
35. Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy.
Zhou W; Yu H; Zhang LJ; Wu B; Wang CX; Wang Q; Deng K; Zhuo RX; Huang SW
Nanoscale; 2017 Nov; 9(43):17044-17053. PubMed ID: 29083424
[TBL] [Abstract][Full Text] [Related]
36. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
Song Y; Tang C; Yin C
Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
[TBL] [Abstract][Full Text] [Related]
37. Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.
Muhammad N; Wang X; Wang K; Zhu C; Zhu Z; Jiao Y; Guo Z
Dalton Trans; 2016 Aug; 45(33):13169-78. PubMed ID: 27333997
[TBL] [Abstract][Full Text] [Related]
38. Involvement of Ca2+ and ROS in alpha-tocopheryl succinate-induced mitochondrial permeabilization.
Gogvadze V; Norberg E; Orrenius S; Zhivotovsky B
Int J Cancer; 2010 Oct; 127(8):1823-32. PubMed ID: 20104525
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine.
Zhang BF; Xing L; Cui PF; Wang FZ; Xie RL; Zhang JL; Zhang M; He YJ; Lyu JY; Qiao JB; Chen BA; Jiang HL
Biomaterials; 2015 Aug; 61():178-89. PubMed ID: 26004233
[TBL] [Abstract][Full Text] [Related]
40. Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles.
Liang D; Wang AT; Yang ZZ; Liu YJ; Qi XR
Mol Pharm; 2015 Jun; 12(6):2189-202. PubMed ID: 25945733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
